Literature DB >> 8417399

Hypertension in infancy.

M M Goble1.   

Abstract

Hypertension in infants is rare and requires a thorough evaluation. The incidence of hypertension in infancy has risen in recent years, reflecting both better monitoring methods and increasingly successful salvage of smaller and smaller newborns. Overall mortality and morbidity rates for uncontrolled hypertension in infants are unknown. With appropriate treatment, the prognosis for resolution of hypertension is good. In most cases, hypertension is short-lived and blood pressures return to normal even when medication is discontinued. Recent experience with improved antihypertensive agents in infancy has meant that nephrectomy for renovascular hypertension is rarely required. There is still much to learn about the indications for treatment of elevated blood pressures in infancy and the potential adverse effects of therapy. Infants with a history of neonatal hypertension should be followed closely because the long-term prognosis is not known and recurrence of hypertension remains a possibility. Because hypertension can develop in high-risk newborns following discharge from the nursery, these infants deserve routine blood pressure measurements as part of their outpatient follow-up.

Entities:  

Mesh:

Year:  1993        PMID: 8417399     DOI: 10.1016/s0031-3955(16)38484-x

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  3 in total

1.  A comparison of blood pressure in term, low birth-weight infants of smoking and nonsmoking mothers.

Authors:  Charlotte J Stark; Mary Beth Flanders Stepans
Journal:  J Perinat Educ       Date:  2004

2.  Renal artery stenosis in infants: long-term medical treatment before surgery.

Authors:  M Bendel-Stenzel; J S Najarian; A R Sinaiko
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

3.  Severe renovascular hypertension in an infant with congenital solitary pelvic kidney.

Authors:  Amira Peco-Antic; Milan Djukic; Dragan Sagic; Divna Kruscic; Zoran Krstic
Journal:  Pediatr Nephrol       Date:  2005-12-29       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.